SalioGen Therapeutics Appoints Jason F. Cole as Chief Executive Officer and Chairman of the Board of Directors
Press Release
July 20, 2022
SalioGen Therapeutics Strengthens its Leadership Team to Advance its Gene Coding™ Platform
Press Release
January 5, 2022
SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene CodingTM – A New Category of Genetic Medicine
Press Release
November 10, 2021
SalioGen Therapeutics Appoints Esteemed Industry Veterans to Executive Advisory Board
Press Release
July 28, 2021
SalioGen Therapeutics Strengthens Management with Key Additions to Leadership Team to Advance Its Gene Coding Platform
Press Release
March 1, 2021
SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Support Advancing a Novel Genome Engineering Platform for Non-Viral Gene Therapy
Press Release
Media
May 6, 2022
Gene Cargos: Building A Bigger Ship
BioProcess Online
April 21, 2022
Genetic medicine: the next generation
Evaluate Vantage
April 7, 2022
Win The CGT Talent Fight: How To Find And Retain Experts
Cell & Gene
March 30, 2022
SalioGen: genome editing without viruses or nucleases (Subscription Required)
BioCentury
March 14, 2022
Lipid Nanoparticle Gene Coding With SalioGen Therapeutics’ Ray Tabibiazar, M.D.
Business of Biotech podcast
March 14, 2022
An Interview with Ray Tabibiazar, M.D., CEO & Chairman of SalioGen Therapeutics
